×

Innovative Multiple Myeloma Drug Being Tested As COVID-19 Treatment

Published May 5, 2020

NOW
PLAYING
Ovarian Cancer - New PARP Inhibitor Combination Drug Approval
NOW
PLAYING
A Great New Option For Multiple Myeloma Patients: Daratumumab Now Available As a Quick Shot, Replacing Long Infusions
NOW
PLAYING
Too Many Cancer Patients Ignoring Life-Threatening Symptoms, Says NYU Oncologist - 'Just Call Us'
NOW
PLAYING
PARP inhibitors and Ovarian Cancer
NOW
PLAYING
What Are The Side Effects Of PARP Inhibitors For Ovarian Cancer Patients?
NOW
PLAYING
Writer Nora Ephron Quietly Fought Acute Myeloid Leukemia (AML)- The Exciting Advances In Treatment
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.